FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine, namely to immunology, and can be used for treatment of immune-mediated disease in mammal which needs it. For this purpose efficient amount of one or more antagonists capable of inhibiting both IL-17A (SEQ ID NO: 3), and IL-17F (SEQ ID NO: 4) in polypeptide IL-17A/F is introduced.
EFFECT: inventions ensure higher efficiency of treatment of immune-mediated diseases, due to novel polypeptide of interleukin17 (IL-17) family.
25 cl, 20 dwg, 9 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-IL-17F ANTIBODIES AND METHODS FOR USE THEREOF | 2010 |
|
RU2605318C2 |
| TRISPECIFIC IL-17A, IL-17F AND OTHER PROINFLAMMATORY MOLECULES ANTIBODIES | 2016 |
|
RU2680011C2 |
| NOVEL IL-17-BINDING COMPOUNDS AND THEIR MEDICINAL APPLICATION | 2010 |
|
RU2550272C2 |
| ANTIBODIES DIRECTED AGAINST IL-17 | 2011 |
|
RU2595385C2 |
| IL-1beta-BINDING ANTIBODIES AND FRAGMENTS THEREOF | 2006 |
|
RU2518295C2 |
| NEW COMPOSITION AND METHODS FOR THERAPY OF IMMNUNE-ASSOCIATED DISEASES WITH IMMUNITY | 2004 |
|
RU2375078C2 |
| ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33) | 2015 |
|
RU2693084C2 |
| DETECTION METHOD OF INTESTINE INFLAMMATORY DISEASE | 2008 |
|
RU2502806C2 |
| ANTIBODIES TO OX-2/CD200 AND THEIR APPLICATION | 2007 |
|
RU2520088C2 |
| CANINE THYMIC STROMAL LYMPHOPOIETIN PROTEIN AND USE THEREOF | 2007 |
|
RU2457217C2 |
